23 July 2020 : Clinical Research
Clinicopathological Analysis and Prognostic Assessment of Transcobalamin I (TCN1) in Patients with Colorectal Tumors
Xinqiang Zhu12ABCDEG*, Kui Yi3BE, Daorong Hou4ADF, Hailong Huang2BC, Xuetong Jiang2ABE, Xiaohong Shi2BCE, Chungen Xing1AEFDOI: 10.12659/MSM.923828
Med Sci Monit 2020; 26:e923828
Table 5 Multivariate analysis of various prognostic parameters in CRC patients with Cox regression analysis.
Prognostic parameters | HR | 95% CI | P value |
---|---|---|---|
Age (≥65 <65) | 4.329 | 1.194–15.695 | 0.026 |
Sex (Male Female) | – | – | – |
CEA | 1.492 | .532–4.197 | 0.447 |
CA125 | 3.732 | 1.371–10.154 | 0.010 |
CA19-9 | 6.045 | 2.017–18.119 | 0.001 |
Tumor grading | 16.132 | 6.673–43.990 | 0.065 |
Depth of invasion | 0.763 | 0.413–1.540 | 0.502 |
Tumor size (≥5 <5) | 1.847 | 0.847–4.578 | 0.126 |
Regional lymph nodes (yes no) | 5.868 | 1.546–22.272 | 0.009 |
Nerve invasion (yes no) | 9.711 | 2.403–39.243 | 0.001 |
Adjuvant chemotherapy (yes no) | 4.128 | 2.226–10.153 | 0.079 |
TCN1 | 1.561 | 0.941–3.002 | 0.073 |
CRC – colorectal cancer; CEA – carcinoembryonic antigen; CA125 – cancer antigen 125; CA19-19 – cancer antigen 19-9. |